Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on XEROS TECHNOLOGY GROUP PLC. We currently have 5 research reports from 2 professional analysts.
|13Mar17 07:00||RNS||Notice of Results|
|03Mar17 16:35||RNS||Price Monitoring Extension|
|02Mar17 14:10||RNS||Holding(s) in Company|
|13Feb17 07:00||RNS||Appointment of Non-Executive Director|
|10Feb17 17:02||RNS||Holding(s) in Company|
|26Jan17 14:18||RNS||Grant of Options|
|19Jan17 07:00||RNS||Trading Update|
Frequency of research reports
Research reports on
XEROS TECHNOLOGY GROUP PLC
XEROS TECHNOLOGY GROUP PLC
Small Cap Breakfast
14 Feb 17
Xafinity –Publication of prospectus. The pensions actuarial, consulting and administration business has conditionally raised £179.6m. At 139p. Due to join main market 16 Feb. Guinness Oil & Gas Exploration—Publication of prospectus. Seeking to raise £50m and invest in 15 exploration companies at launch, with plans to grow the portfolio to 30 positions during its lifetime. Issue closing 23 Feb. Arix Bioscience — Intention to float on the main market from the global healthcare and life science company supporting medical innovation. Raised £52m in Feb 16 with investors including Woodford Investment Management Ramsdens Holdings –Schedule One from the financial services provider and retailer, operating in the core business segments of foreign currency exchange, pawnbroking loans, precious metals buying and selling and retailing of second hand and new jewellery. Expected admission to AIM 15 Feb raising circa £15.6m. Expected mkt cap £26.5m.
16 Jun 16
Consort Medical (CSRT LN) Prelims in line, DEV610 confirmed as generic Advair | Consumer Sector Brexit firmly takes centre stage | Liontrust Asset Management (LIO LN) Positive earnings surprise on performance fees | N Brown Group (BWNG LN) Relief bounce expected on satisfactory Q1 and unchanged guidance | Redcentric (RCN LN) FY results predictably strong | Xeros Technology Group (XSG LN) Capital Markets Day – opportunities look substantial
Capital Markets Day – opportunities look substantial
16 Jun 16
In a series of upbeat presentations at yesterday’s CMD event, Xeros (XSG LN, not rated) maintained the picture of very considerable opportunities to commercialise their polymer beads technology. The initial focus is in commercial laundry, where momentum of installations is accelerating, followed closely by leather processing, where a second full scale trial has just completed. Such is the apparent added value of the sale, that Xeros is looking to establish business models, which in our view should be attractive to investors. While the domestic laundry development has been deemphasised in favour of leather processing (which frankly always looked more visible), the company hints at plenty of other substantial opportunities to deploy the technology. This continues to look like a most interesting situation.
03 Feb 16
BRADY (BRY LN) Value at this level, but deferrals remain a risk | INSTEM PLC (INS LN) Fundraising to accelerate consolidation strategy | LOW & BONAR PLC (LWB LN) Positive progress in difficult markets | WALKER GREENBANK (WGB LN) Trading and flood recovery work on track, including insurer claim | WATERMAN GROUP PLC (WTM LN) Encouraging trading update ahead of interims (29th Feb) | XEROS TECHNOLOGY GROUP PLC (XSG LN) A technology that looks set to clean up
A technology that looks set to clean up
03 Feb 16
This week we met the senior management of Xeros. This company is starting to commercialise a technology platform based around polymer bead chemistry. The first application is now a fully-developed, patented, radically different laundry cleaning process, which reduces water and energy usage by c.50%. These attributes are not at the expense of cleaning performance, which is in fact superior. The company has settled on a business model to supply the commercial laundry market, having appointed distributors across North America and set up a simple service package for customers. The second application in leather processing is currently in full scale trials at a commercial tannery where progress is described as encouraging. We await announcements on further applications of the technology in due course.
N+1 Singer - Morning Song 21-03-2017
21 Mar 17
accesso Technology (ACSO LN) Full year results in line, but key trading months still ahead | Augean (AUG LN) Double digit growth in ’16, good start to ‘17 | Earthport (EPO LN) Interims show continued top line strength | Goals Soccer Centres (GOAL LN) Good momentum under new team. It’s now all about delivery | IQE (IQE LN) FY’16 results prompt further upgrades | Microsaic Systems (MSYS LN) Challenges in 2016, strategy remains in place | mporium Group (MPM LN) Funds raised to help execute strategy | RhythmOne (RTHM LN) Dawn of the independents | ScS Group (SCS LN) Strong progress on key growth initiatives albeit comps now toughen | Sinclair Pharma (SPH LN) FY results: EBITDA ahead, Instalift™ gaining pace | Vectura Group (VEC LN) FY (9-month) results
N+1 Singer - Augean - Double digit growth in ’16, good start to ‘17
21 Mar 17
Augean reported another year of double digit growth for 2016, with profits in line with our forecasts. Sales grew by 21% excluding landfill tax, while adjusted PBT grew by 18% to £7.1m before amortisation of acquired intangibles. DPS was increased by 54% to 1.0p, 25% ahead of our estimate. The business units made further strategic progress, with revenues from their top 20 customers increasing from 42% to 43% of the total, of which 88% was under contract or a framework agreement, increasing forward visibility. There has been an encouraging start to 2017 and management is confident of delivering another year of profits growth. The shares trade on undemanding single digit multiples, offering good value.